Aegon's Q1 2016 Results Impacted by Volatile Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
Mizuho Securities Remains Sidelined on Allergan (AGN) following 1Q Earnings; PT to $232
May 13, 2016 6:52 AM EDTMizuho Securities maintained a Neutral rating on Allergen (NYSE: AGN), and cut the price target to $232.00 (from $250.00), following the company's 1Q earnings report. AGN reported $3.8B in revenues and EPS of $3.04 vs. consensus estimates $3.95B and $3.00. Management reiterated its FY16 revenue guidance of... More
